Wegovy (semaglutide) is an injectable medication prescribed for patients 18 years and older who are:
Obesity (BMI is greater than 30) or
Overweight (excess weight where BMI is greater than 27) and have one or more weight-related conditions such as type 2 diabetes and hypertension.
Wegovy belongs to the drug class, Glucagon-like peptide-1 (GLP-1) receptor agonists. These medications help the body to increase more insulin after eating, which then lowers blood sugar levels.
